Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial, The Lancet, vol.374, issue.9701, pp.1597-1605, 2009. ,
DOI : 10.1016/S0140-6736(09)61836-5
Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis, New England Journal of Medicine, vol.358, issue.21, pp.2240-2248, 2008. ,
DOI : 10.1056/NEJMoa0802315
Effect of Gene Therapy on Visual Function in Leber's Congenital Amaurosis, New England Journal of Medicine, vol.358, issue.21, pp.2231-2239, 2008. ,
DOI : 10.1056/NEJMoa0802268
URL : http://cvrl.ioo.ucl.ac.uk/people/stockman/pubs/2008 gene therapy b et al.pdf
Adenovirus-Associated Virus Vector???Mediated Gene Transfer in Hemophilia B, New England Journal of Medicine, vol.365, issue.25, pp.2357-2365, 2011. ,
DOI : 10.1056/NEJMoa1108046
URL : http://europepmc.org/articles/pmc3265081?pdf=render
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B, New England Journal of Medicine, vol.371, issue.21, pp.1994-2004, 2014. ,
DOI : 10.1056/NEJMoa1407309
Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial, The Lancet, vol.383, issue.9923, pp.1129-1137, 2014. ,
DOI : 10.1016/S0140-6736(13)62117-0
Intramuscular Administration of AAV1-Lipoprotein LipaseS447X Lowers Triglycerides in Lipoprotein Lipase-Deficient Patients, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.28, issue.12, pp.2303-2304, 2008. ,
DOI : 10.1161/ATVBAHA.108.175620
URL : http://atvb.ahajournals.org/content/atvbaha/28/12/2303.full.pdf
) on Postprandial Chylomicron Metabolism in Lipoprotein Lipase-Deficient Patients, The Journal of Clinical Endocrinology & Metabolism, vol.97, issue.5, pp.1635-1644, 2012. ,
DOI : 10.1210/jc.2011-3002
URL : https://academic.oup.com/jcem/article-pdf/97/5/1635/7925516/jcem1635.pdf
Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector, Molecular Therapy, vol.24, issue.2, 2015. ,
DOI : 10.1038/mt.2015.187
Nucleotide sequence and organization of the adeno-associated virus 2 genome, J Virol, vol.45, pp.555-564, 1983. ,
The Assembly-Activating Protein Promotes Capsid Assembly of Different Adeno-Associated Virus Serotypes, Journal of Virology, vol.85, issue.23, pp.12686-12697, 2011. ,
DOI : 10.1128/JVI.05359-11
URL : http://jvi.asm.org/content/85/23/12686.full.pdf
Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells., Proceedings of the National Academy of Sciences, vol.81, issue.20, pp.6466-6470, 1984. ,
DOI : 10.1073/pnas.81.20.6466
URL : http://www.pnas.org/content/81/20/6466.full.pdf
Production of high-titer recombinant adenoassociated virus vectors in the absence of helper adenovirus, J Virol, vol.72, pp.2224-2232, 1998. ,
Manufacturing and Regulatory Strategies for Clinical AAV2-hRPE65, Current Gene Therapy, vol.10, issue.5, pp.341-349, 2010. ,
DOI : 10.2174/156652310793180715